Review
Open access
Sep 2026
Targeting the vascular interface: beyond crossing the blood-brain barrier.
It is proposed that next-generation CNS nanomedicines should be designed by considering therapeutic action at luminal, endothelial, and perivascular sites according to the vascular state of disease, rather than being guided solely by parenchymal delivery.
Ebrahim Sadaqa, A. Hanafy
· Journal of Controlled Releas... · 0 citations